WP
NVO

Westmount Partners’s Novo Nordisk NVO Stock Holding History

Westmount Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,405
Closed -$207K – 245
2024
Q4 		$207K Buy
2,405
+279
+13% +$30.2K 0.06% 208
2024
Q3 		$253K Buy
2,126
+184
+9% +$24.5K 0.08% 188
2024
Q2 		$282K Sell
1,942
-402
-17% -$53.3K 0.09% 165
2024
Q1 		$301K Hold
2,344
– – 0.11% 161
2023
Q4 		$242K Hold
2,344
– – 0.1% 163
2023
Q3 		$213K Buy
+2,344
New +$206K 0.09% 174

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Westmount Partners's NVO Position: Q1 2025 in Review

Westmount Partners sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,405 shares — an estimated $207K sold.

Westmount Partners first reported a position in NVO in Q3 2023 and held it in 6 quarters. The position peaked at $301K in Q1 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Westmount Partners reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Westmount Partners sold 2,405 Novo Nordisk shares in Q1 2025, an estimated $207K.
  • Westmount Partners first reported a position in Novo Nordisk in Q3 2023 and held it in 6 quarters.
  • Westmount Partners's Novo Nordisk position peaked at $301K in Q1 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Westmount Partners's 13F filing for Q1 2025, filed 1 May 2025.